Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Editorial

Published on 15 Sep 2025

Editorial: Bone marrow aging and its impact on immunosenescence in neurological diseases

in Multiple Sclerosis and Neuroimmunology

Junchi He
William G. Kerr
Xingzhi Guo
Dan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1697136

3,419 views

Original Research

Published on 09 Sep 2025

Idiopathic inflammatory myopathy associated with Sjögren’s disease: features of a distinct clinical entity

in Multiple Sclerosis and Neuroimmunology

Franz Felix Konen
Yunus Emre Güzeloglu
Tabea Seeliger
Konstantin Fritz Jendretzky
Sandra Nay
Lea Grote-Levi
Philipp Schwenkenbecher
Christine Gründges
Diana Ernst
Torsten Witte

Frontiers in Immunology

doi 10.3389/fimmu.2025.1654576

3,703 views
2 citations

Original Research

Published on 09 Sep 2025

Anti-neuronal and anti-mitochondrial autoantibodies are associated with lower functional status and more severe respiratory symptoms in post COVID syndrome

in Multiple Sclerosis and Neuroimmunology

Antje Vogelgesang
Anke Steinmetz
Angela Stufano
Valentina Schino
Domenico Plantone
Agnes Flöel
Guglielmo Lucchese

Frontiers in Immunology

doi 10.3389/fimmu.2025.1642250

3,805 views
2 citations

Mini Review

Published on 05 Sep 2025

C/EBPβ as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications

in Multiple Sclerosis and Neuroimmunology

Ji Wang
Yuan Li
Yiyuan Xia

Frontiers in Immunology

doi 10.3389/fimmu.2025.1656165

4,960 views
1 citation

Review

Published on 05 Sep 2025

Neuro-immune axis in atherosclerosis: mechanisms of regulation and therapeutic opportunities

in Multiple Sclerosis and Neuroimmunology

Yuxin Shang
Yuqing Pan
Lingling Xie
Yan Zhao
Wei Mao
Tingting Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1619338

4,783 views

Original Research

Published on 04 Sep 2025

Association of systemic inflammatory factors with clinical outcomes in patients with autoimmune encephalitis at different clinical stages

in Multiple Sclerosis and Neuroimmunology

Bo Jin
Yiqun Duan
Wenxin Wu
Jing Hu
Xiaoyan Wu
Sheng Zhang
Huadong Wu
Thandar Aung

Frontiers in Immunology

doi 10.3389/fimmu.2025.1632690

2,113 views

Original Research

Published on 03 Sep 2025

Gut mycobiota dysbiosis and systemic immune dysfunction in Chinese schizophrenia patients with metabolic syndrome

in Multiple Sclerosis and Neuroimmunology

Zongxin Ling
Yiwen Cheng
Zhiyong Lan
Xia Liu
Zhangcheng Zhu
Wenwen Ding
Xiaocui Xu
Pian Yu
Xiaoxun Xu
Li Shao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652633

2,877 views

Review

Published on 29 Aug 2025

Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect

in Multiple Sclerosis and Neuroimmunology

Zhao Ge
Guoyu Wu
Jingguo Ma
Silin Ren
Tongzuo Liu
Xudong Wu
Xianliang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1631083

5,094 views
1 citation

Systematic Review

Published on 29 Aug 2025

Effects of breathing training on walking ability and quality of life in patients with multiple sclerosis: systematic review and meta-analysis of randomized controlled trials

in Multiple Sclerosis and Neuroimmunology

Cuiting Li
Jihe Kang
Xiuli Wang
Lulu Wang
Xiaoling Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1643938

3,318 views
2 citations

Review

Published on 27 Aug 2025

Neurotrophic factors in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Fabian Güner
Veit Rothhammer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1654603

4,195 views
1 citation

Review

Published on 26 Aug 2025

Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders

in Multiple Sclerosis and Neuroimmunology

Yangchen Zheng
Limin Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1646740

5,578 views
5 citations

Original Research

Published on 26 Aug 2025

Amygdala volume changes as a potential marker of multiple sclerosis progression: links to EDSS scores and PIRA

in Multiple Sclerosis and Neuroimmunology

Aleksandra Pogoda-Wesołowska
Ignacy Stachura
Nina Sługocka
Marta Kania-Pudło
Jacek Staszewski
Adam Stępień

Frontiers in Immunology

doi 10.3389/fimmu.2025.1640607

2,133 views
1 citation

Original Research

Published on 21 Aug 2025

Discovery and early validation of serum protein signatures in untreated multiple sclerosis patients: identification of candidate biomarkers for diagnosis and stratification

in Multiple Sclerosis and Neuroimmunology

Isabel Brichette-Mieg
Ana Alonso-Torres
Pablo Aliaga-Gaspar
José-Luis Rodríguez-Bada
Virginia Reyes-Garrido
Patricia Urbaneja-Romero
Carmen Muñoz
María Díaz-Sánchez
Elisa Martín-Montañez
María-del-Rosario Cabello-Porras

Frontiers in Immunology

doi 10.3389/fimmu.2025.1579045

2,362 views
1 citation

Editorial

Published on 20 Aug 2025

Editorial: Use of big data and artificial intelligence in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Liesbet M. Peeters
Axel Faes
Hans-Peter Hartung

Frontiers in Immunology

doi 10.3389/fimmu.2025.1679482

2,278 views

Original Research

Published on 19 Aug 2025

GM-CSF production by immune cells in steady state and autoimmune neuroinflammation mapped using fate reporting mice

in Multiple Sclerosis and Neuroimmunology

Gholamreza Azizi
Javad Rasouli
Hamed Naziri
Michael V. Gonzalez
James Garifallou
Guang-Xian Zhang
Bogoljub Ciric
Abdolmohamad Rostami

Frontiers in Immunology

doi 10.3389/fimmu.2025.1617074

3,414 views
1 citation

Review

Published on 13 Aug 2025

Homer-3 antibody in autoimmune cerebellar syndromes: a potentially treatable mimic of MSA-C – A review

in Multiple Sclerosis and Neuroimmunology

Patryk Chunowski
Natalia Madetko-Alster
Piotr Alster

Frontiers in Immunology

doi 10.3389/fimmu.2025.1660587

3,475 views
1 citation

Original Research

Published on 07 Aug 2025

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Alexander Rodero-Romero
José Ignacio Fernández-Velasco
Enric Monreal
Raquel Sainz-Amo
Roberto Álvarez-Lafuente
Manuel Comabella
Lluís Ramió-Torrentà
José M. García-Domínguez
Noelia Villarrubia
Susana Sainz de la Maza

Frontiers in Immunology

doi 10.3389/fimmu.2025.1648725

3,882 views
1 citation

Editorial

Published on 07 Aug 2025

Editorial: Microglia and tissue macrophages in pain

in Multiple Sclerosis and Neuroimmunology

Darian Mohsenin
Jessica Yu
Zhonghui Guan
Xiaobing Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1666972

1,936 views

Review

Published on 01 Aug 2025

Immunological microenvironment and targeted therapeutics in multiple sclerosis: new insights in crosstalk between immune niches and CNS

in Multiple Sclerosis and Neuroimmunology

Xiaodi Sun
Feng Zhang
Luojinyun Wang
Gyeore Lee
Sibo Yang
Daqiang Zhou
Bohao Chang
Bo Hu
Yifan Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1604987

4,731 views
2 citations

Original Research

Published on 30 Jul 2025

Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers

in Multiple Sclerosis and Neuroimmunology

Wentong Li
Yiyi Zhang
Chuanhong Li
Mingyang Jiang
Dong Wang
Luomeng Chao
Yuxia Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1615540

3,852 views
2 citations

Original Research

Published on 24 Jul 2025

Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathway

in Multiple Sclerosis and Neuroimmunology

Ariel Rechtman
Omri Zveik
Lyne Shweiki
Garrick Hoichman
Tal Friedman-Korn
Livnat Brill
Adi Vaknin-Dembinsky

Frontiers in Immunology

doi 10.3389/fimmu.2025.1620069

3,408 views
1 citation

Original Research

Published on 24 Jul 2025

Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG

in Multiple Sclerosis and Neuroimmunology

Qingchen Li
Xinyun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610486

2,932 views

Correction

Published on 24 Jul 2025

Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm

in Multiple Sclerosis and Neuroimmunology

Robert Hoffrogge
Anna Karachunskaya
Neele Heitmann
Steffen Haupeltshofer
Xiomara Pedreiturria
Katharina Klöster
Verian Bader
Konstanze F. Winklhofer
Michael Hamacher
Bert Klebl

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652299

1,180 views

Original Research

Published on 24 Jul 2025

Single-nucleus RNA sequencing reveals the specific molecular signatures of myeloid cells responding to brain injury after microglial replacement

in Multiple Sclerosis and Neuroimmunology

Xiao-Yi Xiong
Haicheng Yuan
Ying Mu
Yi He
Fang Xie
Xiao-Shuang Feng
Jia-Xin Xie
Xin-Ru Pan
Yu-Fei Wang
Jian Gong

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625673

3,826 views
2 citations

1,514 articles

articles

Editorial: Bone marrow aging and its impact on immunosenescence in neurological diseases

Idiopathic inflammatory myopathy associated with Sjögren’s disease: features of a distinct clinical entity

Anti-neuronal and anti-mitochondrial autoantibodies are associated with lower functional status and more severe respiratory symptoms in post COVID syndrome

C/EBPβ as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications

Neuro-immune axis in atherosclerosis: mechanisms of regulation and therapeutic opportunities

Association of systemic inflammatory factors with clinical outcomes in patients with autoimmune encephalitis at different clinical stages

Gut mycobiota dysbiosis and systemic immune dysfunction in Chinese schizophrenia patients with metabolic syndrome

Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect

Effects of breathing training on walking ability and quality of life in patients with multiple sclerosis: systematic review and meta-analysis of randomized controlled trials

Neurotrophic factors in multiple sclerosis

Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders

Amygdala volume changes as a potential marker of multiple sclerosis progression: links to EDSS scores and PIRA

Discovery and early validation of serum protein signatures in untreated multiple sclerosis patients: identification of candidate biomarkers for diagnosis and stratification

Editorial: Use of big data and artificial intelligence in multiple sclerosis

GM-CSF production by immune cells in steady state and autoimmune neuroinflammation mapped using fate reporting mice

Homer-3 antibody in autoimmune cerebellar syndromes: a potentially treatable mimic of MSA-C – A review

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

Editorial: Microglia and tissue macrophages in pain

Immunological microenvironment and targeted therapeutics in multiple sclerosis: new insights in crosstalk between immune niches and CNS

Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers

Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathway

Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG

Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm

Single-nucleus RNA sequencing reveals the specific molecular signatures of myeloid cells responding to brain injury after microglial replacement